GH replacement reduces increased lipid peroxidation in GH-deficient adults.

Abstract:

BACKGROUND:GH replacement improves numerous metabolic abnormalities in GH-deficient patients; increased lipid peroxidation (LPO) has been observed in GH-deficient patients; however, it is unknown if LPO is influenced by GH replacement. AIM AND METHODS:To evaluate the extent to which GH replacement might reverse the increased LPO in GH-deficient adults and to analyse if this phenomenon might be involved in the improvement of metabolic disturbances due to GH treatment. Serum concentrations of malondialdehyde + 4-hydroxyalkenals (MDA + 4-HDA), as an index of LPO, were measured at baseline, and after 12 and 24 months of GH replacement in 40 adult patients with severe GH deficiency (both in adult- and childhood-onset) and in 40 healthy volunteers, matched for sex, age and body mass index (BMI). Correlations were evaluated between LPO and lipids, IGF-I, metalloproteinase-2 and -9 (MMP-2, -9), vascular endothelial growth factor (VEGF), BMI and GH dose. RESULTS:LPO values in GH-deficient patients were several-fold higher than in controls [55.36 +/- 2.27 vs. 4.19 +/- 0.42 nmol/mg protein (mean +/- SEM), P < 0.0001] and decreased significantly over time with GH replacement to 38.61 +/- 2.15 nmol/mg protein (i.e. by approximately 30%), though still remaining markedly elevated compared with controls (P < 0.0001). The proatherogenic lipid profile parameters correlated positively with LPO in the childhood-onset subgroup before GH replacement. GH replacement restored the positive correlation between LPO and age in male patients (r = 0.57, P = 0.013; r = 0.8, P < 0.001, at 12 and 24 months of GH replacement, respectively). CONCLUSIONS:GH replacement partially reverses the grossly abnormal LPO in GH-deficient adults. It is highly probable, therefore, that oxidative mechanisms are involved in the overall improvement of metabolic changes due to GH replacement.

journal_name

Clin Endocrinol (Oxf)

journal_title

Clinical endocrinology

authors

Karbownik-Lewinska M,Kokoszko A,Lewandowski KC,Shalet SM,Lewinski A

doi

10.1111/j.1365-2265.2007.03142.x

subject

Has Abstract

pub_date

2008-06-01 00:00:00

pages

957-64

issue

6

eissn

0300-0664

issn

1365-2265

pii

CEN3142

journal_volume

68

pub_type

临床试验,杂志文章
  • Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults.

    abstract:OBJECTIVE:The impact of exogenous GH on thyroid function remains controversial although most data add support to a stimulation of peripheral T4 to T3 conversion. For further elucidation we evaluated iodothyronine and circadian TSH levels in GH-deficient patients as part of a GH dose-response study. PATIENTS:Eight GH-d...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1994.tb01826.x

    authors: Jørgensen JO,Møller J,Laursen T,Orskov H,Christiansen JS,Weeke J

    更新日期:1994-11-01 00:00:00

  • Demonstration of thyroid stimulating activity within H chain fragments of TSAb-IgG by protease digestion and reduction.

    abstract:OBJECTIVE:Whether or not the distribution of biologically active fragments in TSAb-IgG molecules parallels antigen-binding activity in other anti-thyroidal antibodies was examined. DESIGN:Both the thyroid stimulating (TS) activity (cAMP production in thyroid cells) and TSH binding inhibition (TBI) activity (determined...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2265.1997.1110923.x

    authors: Kouki T,Inui T,Hachiya T,Okabe H,Ochi Y,Kajita Y

    更新日期:1997-02-01 00:00:00

  • The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery.

    abstract:OBJECTIVES:Patients undergoing abdominal surgery often suffer from morbidity associated with increased protein catabolism. Therapeutic recombinant human insulin-like growth factor (rhIGF)-I has been proposed as a means of reversing this process. As IGFBPs modulate the bioavailability of the IGFs, we have studied the ch...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2265.1996.649471.x

    authors: Cotterill AM,Mendel P,Holly JM,Timmins AG,Camacho-Hübner C,Hughes SC,Ross RM,Blum WF,Langford RM

    更新日期:1996-01-01 00:00:00

  • Normal VLDL metabolism despite altered lipoprotein composition in type 1 diabetes mellitus.

    abstract:OBJECTIVES:Patients with type 1 diabetes are at increased risk of cardiovascular disease, which may be related to abnormal lipid metabolism. Secretion and clearance of VLDL apolipoprotein B100 (apoB) are important determinants of plasma lipid concentrations and are known to be influenced by hormones, including insulin ...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2265.2001.01407.x

    authors: Christ ER,Carroll PV,Albany E,Umpleby AM,Lumb PJ,Wierzbicki AS,Simpson HL,Sönksen PH,Russell-Ones DL

    更新日期:2001-12-01 00:00:00

  • Preconception management of thyroid dysfunction.

    abstract::Uncorrected thyroid dysfunction in pregnancy has well-recognized deleterious effects on foetal and maternal health. The early gestation period is one of the critical foetal vulnerability during which maternal thyroid dysfunction may have lasting repercussions. Accordingly, a pragmatic preconception strategy is key for...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章,评审

    doi:10.1111/cen.13731

    authors: Okosieme OE,Khan I,Taylor PN

    更新日期:2018-09-01 00:00:00

  • Results of long-term continuous subcutaneous octreotide administration in 14 patients with medullary thyroid carcinoma.

    abstract:OBJECTIVE:Treatment by octreotide has been suggested in medullary thyroid carcinoma patients with post-surgery metastases. The purpose of this study was to evaluate if the tumoral regression could be improved by a high dose and by prolonged octreotide treatment. DESIGN:Fourteen thyroidectomized patients were studied. ...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1992.tb00955.x

    authors: Modigliani E,Cohen R,Joannidis S,Siame-Mourot C,Guliana JM,Charpentier G,Cassuto D,Bentata Pessayre M,Tabarin A,Roger P

    更新日期:1992-02-01 00:00:00

  • Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.

    abstract:BACKGROUND:Between 10 and 30% of the fine needle aspiration biopsies (FNABs) of thyroid nodules are diagnosed as 'indeterminate'. A molecular diagnostic method is needed to reduce unnecessary surgery in this group. In Korea, most thyroid cancer is the classic papillary type and the BRAF(V600E) mutation is highly preval...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.2006.02646.x

    authors: Chung KW,Yang SK,Lee GK,Kim EY,Kwon S,Lee SH,Park DJ,Lee HS,Cho BY,Lee ES,Kim SW

    更新日期:2006-11-01 00:00:00

  • SRY-negative 46,XX testicular/ovotesticular DSD: Long-term outcomes and early blockade of gonadotropic axis.

    abstract:OBJECTIVE:SRY-negative 46,XX testicular and ovotesticular disorders/differences of sex development (T/OTDSD) represent a very rare and unique DSD condition where testicular tissue develops in the absence of a Y chromosome. To date, very few studies have described the phenotype, clinical and surgical management and long...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/cen.14389

    authors: Lambert S,Peycelon M,Samara-Boustani D,Hyon C,Dumeige L,Peuchmaur M,Fiot E,Léger J,Simon D,Paye-Jaouen A,Bouligand J,Siffroi JP,Carel JC,McElreavey K,El Ghoneimi A,Brachet C,Bouvattier C,Martinerie L

    更新日期:2020-12-09 00:00:00

  • GH-secreting pituitary adenomas infrequently contain inactivating mutations of PRKAR1A and LOH of 17q23-24.

    abstract:OBJECTIVE:The molecular events leading to the development of GH-secreting pituitary tumours remain largely unknown. Gsalpha (GNAS1) mutations are found in 27-43% of sporadic GH-secreting adenomas in the Caucasian population, but the frequency of GNAS1 mutations in Japanese and Korean acromegalic patients was reported t...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2265.2003.01740.x

    authors: Yamasaki H,Mizusawa N,Nagahiro S,Yamada S,Sano T,Itakura M,Yoshimoto K

    更新日期:2003-04-01 00:00:00

  • Ovarian and placental hormones during prolactin suppression and stimulation in early human pregnancy.

    abstract::Twenty-seven healthy females referred for legal abortion between the sixth and ninth week of pregnancy were treated for 1 week with either bromocriptine, metoclopramide or placebo. Serum prolactin was significantly (P < 0.01) elevated by metoclopramide and suppressed by bromocriptine. Despite a more than tenfold diffe...

    journal_title:Clinical endocrinology

    pub_type: 临床试验,杂志文章

    doi:10.1111/j.1365-2265.1980.tb01036.x

    authors: Andersen AN,Hertz J,Kjer JJ,Eskildsen PC,Larsen PS,Svenstrup B,Nielsen J,Arends J

    更新日期:1980-08-01 00:00:00

  • Quantitative growth hormone secretion and final adult height.

    abstract:OBJECTIVE:The relationship of quantitative GH secretion to height, growth velocity and puberty is complex and has been the subject of extensive study in children. This study was designed to relate quantitative GH secretion to final height. SUBJECTS:Twenty tall (> 183 cm, 90th centile for adult height) and 20 short (< ...

    journal_title:Clinical endocrinology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1046/j.1365-2265.1999.00844.x

    authors: Trainer PJ,Palermo M,Kirk JM,Fanciulli G,Perry LH,Delitala G,Besser GM

    更新日期:1999-11-01 00:00:00

  • Growth hormone (GH) status is an independent determinant of serum levels of cholesterol and triglycerides in healthy adults.

    abstract:OBJECTIVE:Both severe growth hormone (GH) deficiency in hypopituitary adults and physiological ageing are associated with an increase in fat mass, dyslipidaemia, and an increased incidence of cardiovascular disease. Ageing is also associated with a physiological decrease in spontaneous as well as stimulated GH secretio...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2265.1999.00772.x

    authors: Vahl N,Klausen I,Christiansen JS,Jørgensen JO

    更新日期:1999-09-01 00:00:00

  • Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy.

    abstract:OBJECTIVE:Adult onset GH deficiency (GHD) is characterized by abnormalities of serum lipoprotein profiles and GH replacement results in favourable alterations in serum total and low density lipoprotein (LDL)-cholesterol. Preliminary evidence has indicated that the effect of GH replacement in this respect may be additiv...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.2007.02935.x

    authors: Monson JP,Jönsson P,Koltowska-Häggström M,Kourides I

    更新日期:2007-10-01 00:00:00

  • Utility of I-124 PET/CT in identifying radioiodine avid lesions in differentiated thyroid cancer: a systematic review and meta-analysis.

    abstract:INTRODUCTION:Diagnostic I-123 scans have been shown to underestimate the disease burden in differentiated thyroid cancer (DTC) when compared to I-131 post-treatment scans, especially in children and patients who have had prior radioiodine (RAI) therapy and/or distant metastasis. I-124 PET/CT has been shown to be highly...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章,meta分析,评审

    doi:10.1111/cen.13306

    authors: Santhanam P,Taieb D,Solnes L,Marashdeh W,Ladenson PW

    更新日期:2017-05-01 00:00:00

  • Comparative effects of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves' disease.

    abstract::Patients with thyrotoxic Graves' disease were treated daily for 10 d with 1 g sodium ipodate, an iodine rich X-ray contrast agent which impairs outer ring (5'-) deiodination of T4 to T3, or with 12 drops of a saturated solution of potassium iodide (SSKI). T4, T3 and reverse T3 (rT3) concentrations were measured before...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1985.tb00148.x

    authors: Roti E,Robuschi G,Manfredi A,D'Amato L,Gardini E,Salvi M,Montermini M,Barlli AL,Gnudi A,Braverman LE

    更新日期:1985-04-01 00:00:00

  • Individual neurophysin concentrations in the pituitary and circulation of humans.

    abstract::Specific, homologous human neurophysin I and II radioimmunoassays were established and used to measure the individual, immunoreactive neurophysin concentrations in human plasma. Circulating levels of human neurophysin I in normal individuals were less than 1 ng/ml and neurophysin II levels were 1-2 ng/ml. During dehyd...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1979.tb02079.x

    authors: Dax EM,Clappison BH,Pullan PT,Pepperell R,Johnston CI

    更新日期:1979-03-01 00:00:00

  • Suppression of parathyroid hormone inhibitory activity of plasma in pseudohypoparathyroidism type I by i.v. calcium.

    abstract::The biological response, as measured in the cytochemical bioassay, to the high circulating levels of immunoreactive parathyroid hormone (iPTH) in patients with pseudohypoparathyroidism type I (PSPI) is affected by the presence of an endogenous inhibitor. This is evidenced by the reduced recovery of the biological acti...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1986.tb03284.x

    authors: Loveridge N,Fischer JA,Devogelaer JP,Nagant de Deuxchaisnes C

    更新日期:1986-05-01 00:00:00

  • The effects of chronic treatment with LHRH on gonadotrophin secretion and pituitary responsiveness to LHRH in women with secondary hypogonadism.

    abstract::Twenty women with secondary hypogonadism and four normal women in the early follicular phase of the cycle were treated for 7 days with 10, 50 or 100 micrograms synthetic LHRH administered intramuscularly at 4 h intervals. Concentrations of pituitary and ovarian hormones in plasma were measured at intervals during the ...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1983.tb00737.x

    authors: Vaughan Williams CA,McNeilly AS,Baird DT

    更新日期:1983-07-01 00:00:00

  • Persistent centripetal fat distribution and metabolic abnormalities in patients in long-term remission of Cushing's syndrome.

    abstract:OBJECTIVE:Centripetal obesity is associated with systemic low-grade inflammation and an increased cardiovascular risk. Patients in long-term remission of Cushing's syndrome (CS) report persisting abdominal fat accumulation. However, this has previously not been adequately objectified. Therefore, we investigated the adi...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/cen.12639

    authors: Wagenmakers M,Roerink S,Gil L,Plantinga T,Smit J,Netea-Maier R,Hermus A

    更新日期:2015-02-01 00:00:00

  • Iodine deficiency amongst pregnant women in South-West England.

    abstract:INTRODUCTION:Iodine deficiency in pregnancy may impair foetal neurological development. The UK population is generally thought to be iodine sufficient; however, recent studies have questioned this assumption. Our study aimed to explore the prevalence of iodine deficiency in a cohort of pregnant mothers from South-West ...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/cen.13268

    authors: Knight BA,Shields BM,He X,Pearce EN,Braverman LE,Sturley R,Vaidya B

    更新日期:2017-03-01 00:00:00

  • Insulin-like growth factor-II: its role in metabolic and endocrine disease.

    abstract::Insulin-like growth factor-II (IGF-II) is a widely expressed 7·5 kDa mitogenic peptide hormone. Although it is abundant in serum, understanding of its physiological role is limited compared with that of IGF-I. IGF-II regulates foetal development and differentiation, but its role in adults is less well understood. Evid...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章,评审

    doi:10.1111/cen.12446

    authors: Livingstone C,Borai A

    更新日期:2014-06-01 00:00:00

  • Clearance and identification of thyrotrophin releasing hormone in human urine after intravenous injections.

    abstract::The urine clearance of TRH after intravenous injection in man has been measured by radioimmunoassay. Between 4.4 percent and 10.7 percent of the dose was excreted within 90 min, the majority within 30 min. The TRH excreted was immunochemically and chromatographically indistinguishable from synthetic TRH and was inacti...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1975.tb01549.x

    authors: Jeffcoate SL,White N

    更新日期:1975-07-01 00:00:00

  • Evaluation of two inhibitory tests (nomifensine and L-dopa + carbidopa) for the diagnosis of hyperprolactinaemic states.

    abstract::It has been reported that administration of nomifensine (Nom) or of L-dopa + carbidopa (L-dopa + Carb) potentiates central dopaminergic tonus, resulting in decreased prolactin (PRL) secretion. It has been proposed that these drugs would help to discriminate patients with PRL-secreting pituitary tumours from those with...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/j.1365-2265.1980.tb03420.x

    authors: Moriondo P,Travaglini P,Nissim M,Faglia G

    更新日期:1980-12-01 00:00:00

  • Elevated fibrinogen levels decrease following treatment of acromegaly.

    abstract:OBJECTIVE:Acromegaly is associated with increased morbidity and mortality from cardiovascular disease and from stroke in particular. Fibrinogen is an established risk factor for stroke and myocardial infarction and high levels of plasminogen activator inhibitor-1 (PAI-1) activity were predictive of a recurrent myocardi...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2265.1997.d01-1743.x

    authors: Landin-Wilhelmsen K,Tengborn L,Wilhelmsen L,Bengtsson BA

    更新日期:1997-01-01 00:00:00

  • Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects.

    abstract:OBJECTIVE:Subclinical hypercortisolism (SH) has been associated with increased prevalence of hypertension, type 2 diabetes mellitus, dyslipidaemia, central obesity, osteoporosis and vertebral fractures. We aimed to investigate the accuracy of different SH diagnostic criteria in predicting the presence of complications....

    journal_title:Clinical endocrinology

    pub_type: 杂志文章,多中心研究

    doi:10.1111/j.1365-2265.2010.03794.x

    authors: Morelli V,Masserini B,Salcuni AS,Eller-Vainicher C,Savoca C,Viti R,Coletti F,Guglielmi G,Battista C,Iorio L,Beck-Peccoz P,Ambrosi B,Arosio M,Scillitani A,Chiodini I

    更新日期:2010-08-01 00:00:00

  • Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.

    abstract:OBJECTIVE:To evaluate the effect of hyperprolactinaemia and its treatment with dopamine-agonists on bone mass and turnover in adolescent patients compared to adults. PATIENTS:Forty patients with hyperprolactinaemia (20 with disease onset during adolescence and 20 during adulthood) and 40 healthy control subjects. DES...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2265.2000.00902.x

    authors: Colao A,Di Somma C,Loche S,Di Sarno A,Klain M,Pivonello R,Pietrosante M,Salvatore M,Lombardi G

    更新日期:2000-03-01 00:00:00

  • Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation.

    abstract:OBJECTIVE:This study was designed to investigate whether an elevated serum antithyroglobulin antibody (TgAb) reflects cancer recurrence in thyroglobulin (Tg)-undetectable patients with differentiated thyroid carcinoma (DTC) after thyroid ablation. DESIGN:We measured serum TgAb level and evaluated the disease status in...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1046/j.1365-2265.2002.01592.x

    authors: Chung JK,Park YJ,Kim TY,So Y,Kim SK,Park DJ,Lee DS,Lee MC,Cho BY

    更新日期:2002-08-01 00:00:00

  • A ten-year clinical update of a large RET p.Gly533Cys kindred with medullary thyroid carcinoma emphasizes the need for an individualized assessment of affected relatives.

    abstract:OBJECTIVE:Reviewing the clinical outcomes of a large kindred with a RET p.Gly533Cys mutation, 10 years after the first description of this kindred, has provided an important set of clinical data for healthcare decision-making. DESIGN AND PATIENTS:We identified 728 RET533 Brazilian relatives, spread out over 7 generati...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章

    doi:10.1111/cen.12264

    authors: Signorini PS,França MI,Camacho CP,Lindsey SC,Valente FO,Kasamatsu TS,Machado AL,Salim CP,Delcelo R,Hoff AO,Cerutti JM,Dias-da-Silva MR,Maciel RM

    更新日期:2014-02-01 00:00:00

  • Effect of naloxone on neurohypophyseal peptide responses to breast feeding and breast stimulation in man.

    abstract::We have investigated the role of endogenous opioid peptides in the release of oxytocin (OT) in response to breast feeding and breast stimulation in humans. Five breast feeding women were studied on two separate occasions within 4 weeks of delivery. Saline or naloxone, 4 mg bolus and 6 mg/h, was administered intravenou...

    journal_title:Clinical endocrinology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1365-2265.1990.tb00468.x

    authors: Johnson MR,Andrews MA,Seckl JR,Lightman SL

    更新日期:1990-07-01 00:00:00

  • Metabolic outcome of GH treatment in prepubertal short children with and without classical GH deficiency.

    abstract:CONTEXT:Few studies have evaluated the metabolic outcomes of growth hormone (GH) treatment in idiopathic short stature (ISS). Moreover, children with ISS appear to need higher GH doses than children with GH deficiency (GHD) to achieve the same amount of growth and may therefore be at increased risk of adverse events du...

    journal_title:Clinical endocrinology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1111/j.1365-2265.2010.03812.x

    authors: Decker R,Albertsson-Wikland K,Kriström B,Nierop AF,Gustafsson J,Bosaeus I,Fors H,Hochberg Z,Dahlgren J

    更新日期:2010-09-01 00:00:00